SCHEMBL27423920

SCHEMBL27423920

N=C(N)NCCCC1NC(=O)CNC(=O)CNC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)CNC1=O

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MC4R P32245 9/20 0.48
MC5R P33032 9/20 0.48
MC3R P41968 9/20 0.48
MC1R Q01726 9/20 0.48
CXCR4 P61073 1/20 0.48
ITGB3 P05106 10/20 0.47
ITGAV P06756 6/20 0.47
ITGB5 P18084 3/20 0.47
ITGA2B P08514 4/20 0.47
ITGB1 P05556 1/20 0.47
ITGA5 P08648 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8207851 1.00 MC4R (0.48) MC4RMC5RMC3RMC1RCXCR4
SCHEMBL29568895 0.94 ITGB3 (0.51) MC4RMC5RMC3RMC1RCXCR4
SCHEMBL18968797 0.94 ITGB3 (0.51) MC4RMC5RMC3RMC1RCXCR4
SCHEMBL29569086 0.92 ITGB3 (0.49) MC4RMC5RMC3RMC1RCXCR4
SCHEMBL24975089 0.91 ITGB3 (0.54) MC4RMC5RMC3RMC1RITGB3
SCHEMBL30121071 0.91 ITGB3 (0.50) MC4RMC5RMC3RMC1RCXCR4
SCHEMBL20888358 0.91 ITGB3 (0.58) MC4RMC5RMC3RMC1RITGB3
SCHEMBL21766911 0.91 ITGB3 (0.58) MC4RMC5RMC3RMC1RITGB3
SCHEMBL30121037 0.91 ITGB3 (0.50) MC4RMC5RMC3RMC1RCXCR4
SCHEMBL19605458 0.91 ITGB3 (0.58) MC4RMC5RMC3RMC1RITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024092256-A2 PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-05-02 WO disclosed